Home/Third Harmonic Bio/Natalie Holles, J.D.

NH

Natalie Holles, J.D.

Chief Executive Officer and Chair of the Board

Third Harmonic Bio

Therapeutic Areas

Allergy & Immunology Inflammatory Diseases Fibrotic Diseases

Third Harmonic Bio Pipeline

Drug	Indication	Phase
THB001	Chronic Spontaneous Urticaria (CSU)	Phase 1b
THB222	Fibrotic Diseases	Preclinical

Leadership Team at Third Harmonic Bio

Ian M. Smith, Ph.D.

Chief Scientific Officer

Paul D. Rubin, M.D.

Chief Medical Officer

Michael Andreeff, M.B.A., C.P.A.

Chief Financial Officer

Paul G. Pearson, Ph.D.

Chief Development Officer

Chairman of the Board (Lead Independent Director)

View full Third Harmonic Bio profile